GulfBase Live Support
24/12/2017 06:18 AST
National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a rights issue. The company has received approval from the Capital Market Authority (CMA) for the rights issue and accordingly, 50 million shares will be issued to the existing shareholders at a price of 102 baisas per share.
The board of directors of the company approved a proposal to raise of the company's capital from OMR5 million to OMR10 million.
The CMA approved the rights issue prospectus based on the request of the company's management and in compliance with all the requirements of the issue.
Times of Oman
Ticker | Price | Volume |
---|
17/04/2025
Bullish on Qatar's macroeconomic prospects, Al Mahhar Holding is exploring options on expanding its manufacturing base for the energy sector over the medium term and aims to diversify into renewables
The Peninsula
17/04/2025
Abu Dhabi-based global entities ADQ, IHC and Modon Holding have entered into a joint venture to form a dedicated infrastructure platform - Gridora - that will actively drive infrastructure developmen
Trade Arabia
17/04/2025
The Zain Group Annual General Meeting (AGM) was held at the Zain Group's headquarters in Kuwait, attended with a quorum of 79.2% of shareholders whereby they were presented with the Zain Group's 2024
Kuwait Times
17/04/2025
Al Meera Consumer Goods Company is strengthening efforts to digitise platforms and expand self-checkout as part of its continued strategies to improve services to customers.
"Looking towards
Gulf Times
16/04/2025
Commercial Bank, a leader in innovative digital banking solutions in Qatar, in collaboration with Microsoft, hosted the first DHL4SMEs workshop on digital and financial strategies for SMEs at Commerc
The Peninsula